MHDC Technical Partnership with UMFCCI-CSR under the Global Fund RAI2E & RAI3E (2019–2023)
From 2019 to 2023, the UMFCCI Corporate Social Responsibility (CSR) Unit served as a sub-recipient of the Global Fund to Fight AIDS, Tuberculosis and Malaria under the Regional Artemisinin-Resistance Initiative – Elimination (RAI2E and RAI3E). The project, funded through the Global Fund Regional Steering Committee, implemented a pioneering public–private partnership model for malaria elimination in Myanmar.
MHDC served as Technical Partner across both funding cycles, providing strategic oversight and coordination in collaboration with the National Malaria Control Programme (NMCP) and UNOPS as Principal Recipient.
Key Achievements (2019–2023)
-
Established a structured model engaging the non-health corporate sector in malaria elimination
-
Trained 77 worksite Integrated Community Malaria Volunteers (ICMVs) covering over 30 communities in 7 townships of Mon State
-
Conducted nearly 1,200 malaria tests in 2023 through volunteer-led workplace initiatives
-
Delivered 25 tonnes of malaria and essential health commodities, including Abate sand granules, to Mon and Rakhine States, with an average delivery time of 3.4 days
-
Held 61 engagement meetings with 224 private sector counterparts, strengthening cross-sector collaboration
-
Expanded access to prevention, early diagnosis, referral, and surveillance services for migrant workers, forest-goers, and other mobile populations
The initiative demonstrated that structured private sector engagement can significantly enhance malaria service delivery in high-risk and hard-to-reach settings, contributing to Myanmar’s national elimination goals and the broader Greater Mekong Subregion (GMS) strategy.
Recent Comments